Reneo Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 1.53 K | $2.59 K | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| STATE STREET CORP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| BANK OF MONTREAL /CAN/ | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| MARQUETTE ASSET MANAGEMENT, LLC | 01/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ALDEBARAN CAPITAL, LLC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JBF CAPITAL, INC. | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ACUITAS INVESTMENTS, LLC | 01/31/2025 | 0 | $0 | -100.00% | 0.00% |
| CARLYLE GROUP INC. | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/27/2025 | 0 | $0 | -100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 02/05/2025 | 0 | $0 | -100.00% | 0.00% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| SHAY CAPITAL LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| AISLING CAPITAL MANAGEMENT LP | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CORNERSTONE PLANNING GROUP LLC | 01/29/2025 | 0 | $0 | -100.00% | 0.00% |
| OCTAGON CAPITAL ADVISORS LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 0 | $0 | -100.00% | 0.00% |
| VESTAL POINT CAPITAL, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK, INC. | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Reneo Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of Reneo Pharmaceuticals, Inc.. The most heavily invested institutionals were:
ADVISOR GROUP HOLDINGS, INC.: 0
RiverVest Venture Management LLC: 2.53 M
BlackRock Inc.: 293,651
Point72 Middle East FZE: 13,946
Abingworth LLP: 2.07 M
Amalgamated Financial Corp.: 1,319
0.00% of Reneo Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 4.92 M shares in the last 24 months. This purchase volume represents approximately $89.49 M in transactions.